Definium Therapeutics (DFTX) total assets

Total assets · fiscal 2025
$440.10M

Definium Therapeutics (DFTX) had total assets of $440.10M at the end of fiscal 2025 (December 31, 2025). That is 45.7% higher than the $302.15M of fiscal 2024. Figures as of 18 Nov 2026, 01:37 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$440.10M
Change on fiscal 2024
+45.7%
Growth, 5 years
+40.1% a year
Highest on record
$440.10Mfiscal 2025
Lowest on record
$81.52Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Definium Therapeutics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 40.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was $440.10M in fiscal 2025 and the lowest $81.52M in fiscal 2020.

History · 6 fiscal years

Total assets by fiscal year

Definium Therapeutics total assets, year by year

Definium Therapeutics (DFTX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$440.10M 45.7% up
2024$302.15M 142.6% up
2023$124.54M 26.7% down
2022$169.99M 3.7% up
2021$164.00M 101.2% up
2020$81.52M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Definium Therapeutics and comparable companies
CompanyTotal assetsFiscal year
Heartflow HTFL$359.45M2025
CRISPR Therapeutics CRSP$2.27B2025
Travere Therapeutics TVTX$605.19M2025
Option Care Health OPCH$3.46B2025
Legend Biotech LEGN$1.73B2025
Definium Therapeutics DFTX$440.10M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on DFTX

Definium Therapeutics, figure by figure

Definium Therapeutics (DFTX) overview: price, valuation and scorecardAll health care companies by market value

Definium Therapeutics total assets: questions and answers

How large are Definium Therapeutics's total assets?

Definium Therapeutics (DFTX) had total assets of $440.10M at the end of fiscal 2025 (December 31, 2025). That is 45.7% higher than the $302.15M of fiscal 2024.

What is the growth rate of Definium Therapeutics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 40.1% a year.

What are the highest and lowest total assets figures on record for Definium Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was $440.10M in fiscal 2025 and the lowest $81.52M in fiscal 2020.

How is Definium Therapeutics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Definium Therapeutics (DFTX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/DFTX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.